Competent Cells Market: By Type (Electro Competent Cells, Chemically Competent Cells) By Application (Protein Expression, Cloning, Mutagenesis, Lenti Viral Vector Production, Large Plasmid Transformation) By End-user (Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Contract Research Organizations) and By Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Competent Cells Market size was valued at USD 2.6 billion in 2023, growing at a CAGR of 12.2% from 2024-2030. The alterations of E. coli cell walls enable pass DNA more easily. These types of cells are known as competent cells. Heat shock and calcium chloride methods are used to prepare competent cells. Bacterial cells that receive additional chromosomal DNA and plasmids are known as competent cells. Calcium chloride and heat shock are used to permeate the walls of competent cells. This procedure comprises chilling the bacteria with calcium chloride at 0 degrees Celsius for around 90 seconds then heating them at 47 degrees Celsius for another 90 seconds. The calcium chloride treatment neutralizes the membrane's repulsive action of phospholipid heads, while the heat process provides a temperature gradient that allows DNA to enter competent cells. Cells in the early stages of development are more competent than those in the later stages. In the transformation process, competent cells are utilized.

   

 

Competent Cells Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

12.2%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Competent Cells Market Dynamics

Increase in advancements in research of molecular cloning, advent of innovative technologies is expected to drive global competent cells market. Moreover, rise in adoption of competent cells, growing commercial demand for molecular cloned products are expected to trigger the revenue share for competent cells market. However, lack of awareness regarding competent cells, high cost associated with the manufacturing procedures, stringent government regulations are restraints of Global market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Competent Cells Market Segmentation

By Type
  • Electro Competent Cells
  • Chemically Competent Cells
By Application
  • Protein Expression
  • Cloning
  • Mutagenesis
  • Lenti-Viral Vector Production
  • Large Plasmid Transformation
By End User
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Research Institutes
  • Contract Research Organizations

Frequently Asked Questions

The competent cells market market size was valued at USD 2.6 billion in 2023

The competent cells market key players are: Bio Dynamics Laboratory (Japan) GCC Biotech (India) SMOBIO Technology (Taiwan) Thermo Fisher Scientific, Inc. (U.S.) QIAGEN N.V. (Germany) OriGene Technologies (U.S.) Merck & Co (Germany) Promega Corporation (U.S.) Bioline (UK) Zymo Research (U.S.)

The competent cells market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

1. Executive Summary
2. Global Competent Cells Market Introduction 
2.1.Global Competent Cells Market  - Taxonomy
2.2.Global Competent Cells Market  - Definitions
2.2.1.Type 
2.2.2.Application
2.2.3.End Users
2.2.4.Region
3. Global Competent Cells Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Competent Cells Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Competent Cells Market  By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Electro Competent Cells
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Chemically Competent Cells
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6. Global Competent Cells Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Protein Expression
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Cloning
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Mutagenesis
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Lenti-Viral Vector Production
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Large Plasmid Transformation
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7. Global Competent Cells Market  By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Pharmaceutical Companies
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Biotechnology Companies
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Research Institutes
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Contract Research Organizations
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8. Global Competent Cells Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Competent Cells Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Electro Competent Cells
9.1.2.Chemically Competent Cells
9.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Protein Expression
9.2.2.Cloning
9.2.3.Mutagenesis
9.2.4.Lenti-Viral Vector Production
9.2.5.Large Plasmid Transformation
9.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Pharmaceutical Companies
9.3.2.Biotechnology Companies
9.3.3.Research Institutes
9.3.4.Contract Research Organizations
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Competent Cells Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Electro Competent Cells
10.1.2.Chemically Competent Cells
10.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Protein Expression
10.2.2.Cloning
10.2.3.Mutagenesis
10.2.4.Lenti-Viral Vector Production
10.2.5.Large Plasmid Transformation
10.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Pharmaceutical Companies
10.3.2.Biotechnology Companies
10.3.3.Research Institutes
10.3.4.Contract Research Organizations
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11. Asia Pacific (APAC) Competent Cells Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Electro Competent Cells
11.1.2.Chemically Competent Cells
11.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Protein Expression
11.2.2.Cloning
11.2.3.Mutagenesis
11.2.4.Lenti-Viral Vector Production
11.2.5.Large Plasmid Transformation
11.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Pharmaceutical Companies
11.3.2.Biotechnology Companies
11.3.3.Research Institutes
11.3.4.Contract Research Organizations
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Competent Cells Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Electro Competent Cells
12.1.2.Chemically Competent Cells
12.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Protein Expression
12.2.2.Cloning
12.2.3.Mutagenesis
12.2.4.Lenti-Viral Vector Production
12.2.5.Large Plasmid Transformation
12.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Pharmaceutical Companies
12.3.2.Biotechnology Companies
12.3.3.Research Institutes
12.3.4.Contract Research Organizations
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Competent Cells Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Electro Competent Cells
13.1.2.Chemically Competent Cells
13.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Protein Expression
13.2.2.Cloning
13.2.3.Mutagenesis
13.2.4.Lenti-Viral Vector Production
13.2.5.Large Plasmid Transformation
13.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Pharmaceutical Companies
13.3.2.Biotechnology Companies
13.3.3.Research Institutes
13.3.4.Contract Research Organizations
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Bio Dynamics Laboratory (Japan)
14.2.2.GCC Biotech (India)
14.2.3.SMOBIO Technology (Taiwan)
14.2.4.Thermo Fisher Scientific, Inc. (U.S.)
14.2.5.QIAGEN N.V. (Germany)
14.2.6.OriGene Technologies (U.S.)
14.2.7.Merck & Co (Germany)
14.2.8.Promega Corporation (U.S.)
14.2.9.Bioline (UK)
14.2.10.Zymo Research (U.S.)
15. Research Methodology 
16. Appendix and Abbreviations 
  • Bio Dynamics Laboratory (Japan)
  • GCC Biotech (India)
  • SMOBIO Technology (Taiwan)
  • Thermo Fisher Scientific, Inc. (U.S.)
  • QIAGEN N.V. (Germany)
  • OriGene Technologies (U.S.)
  • Merck & Co (Germany)
  • Promega Corporation (U.S.)
  • Bioline (UK)
  • Zymo Research (U.S.)

Adjacent Markets